nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—CYP3A7—Ifosfamide—testicular cancer	0.105	0.144	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.105	0.144	CbGbCtD
Clarithromycin—SLC22A7—Methotrexate—testicular cancer	0.0856	0.117	CbGbCtD
Clarithromycin—CYP3A5—Ifosfamide—testicular cancer	0.0789	0.108	CbGbCtD
Clarithromycin—CYP2C19—Ifosfamide—testicular cancer	0.0637	0.0873	CbGbCtD
Clarithromycin—ABCB1—Dactinomycin—testicular cancer	0.0435	0.0596	CbGbCtD
Clarithromycin—CYP3A5—Etoposide—testicular cancer	0.0377	0.0517	CbGbCtD
Clarithromycin—CYP3A4—Ifosfamide—testicular cancer	0.0308	0.0422	CbGbCtD
Clarithromycin—CYP1A2—Etoposide—testicular cancer	0.0281	0.0385	CbGbCtD
Clarithromycin—ABCB1—Vinblastine—testicular cancer	0.0272	0.0374	CbGbCtD
Clarithromycin—ABCB1—Cisplatin—testicular cancer	0.025	0.0343	CbGbCtD
Clarithromycin—ABCB1—Etoposide—testicular cancer	0.0245	0.0337	CbGbCtD
Clarithromycin—ABCB1—Doxorubicin—testicular cancer	0.0167	0.023	CbGbCtD
Clarithromycin—CYP3A4—Vinblastine—testicular cancer	0.0163	0.0224	CbGbCtD
Clarithromycin—ABCB1—Methotrexate—testicular cancer	0.0162	0.0222	CbGbCtD
Clarithromycin—CYP3A4—Etoposide—testicular cancer	0.0147	0.0202	CbGbCtD
Clarithromycin—CYP3A4—Doxorubicin—testicular cancer	0.01	0.0138	CbGbCtD
Clarithromycin—Urethral disorder—Methotrexate—testicular cancer	0.000199	0.000735	CcSEcCtD
Clarithromycin—Feeling abnormal—Etoposide—testicular cancer	0.000198	0.000733	CcSEcCtD
Clarithromycin—Nausea—Dactinomycin—testicular cancer	0.000198	0.00073	CcSEcCtD
Clarithromycin—Agranulocytosis—Epirubicin—testicular cancer	0.000197	0.00073	CcSEcCtD
Clarithromycin—Pneumonia—Doxorubicin—testicular cancer	0.000197	0.000728	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Etoposide—testicular cancer	0.000197	0.000727	CcSEcCtD
Clarithromycin—Infestation NOS—Doxorubicin—testicular cancer	0.000196	0.000723	CcSEcCtD
Clarithromycin—Infestation—Doxorubicin—testicular cancer	0.000196	0.000723	CcSEcCtD
Clarithromycin—Visual impairment—Methotrexate—testicular cancer	0.000196	0.000723	CcSEcCtD
Clarithromycin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000194	0.000717	CcSEcCtD
Clarithromycin—Vomiting—Ifosfamide—testicular cancer	0.000194	0.000716	CcSEcCtD
Clarithromycin—Hypersensitivity—Cisplatin—testicular cancer	0.000194	0.000715	CcSEcCtD
Clarithromycin—Renal failure—Doxorubicin—testicular cancer	0.000192	0.000711	CcSEcCtD
Clarithromycin—Rash—Ifosfamide—testicular cancer	0.000192	0.00071	CcSEcCtD
Clarithromycin—Dermatitis—Ifosfamide—testicular cancer	0.000192	0.00071	CcSEcCtD
Clarithromycin—Erythema multiforme—Methotrexate—testicular cancer	0.000192	0.000709	CcSEcCtD
Clarithromycin—Urticaria—Etoposide—testicular cancer	0.000191	0.000707	CcSEcCtD
Clarithromycin—Haemoglobin—Epirubicin—testicular cancer	0.000191	0.000705	CcSEcCtD
Clarithromycin—Jaundice—Doxorubicin—testicular cancer	0.000191	0.000705	CcSEcCtD
Clarithromycin—Stomatitis—Doxorubicin—testicular cancer	0.000191	0.000705	CcSEcCtD
Clarithromycin—Rhinitis—Epirubicin—testicular cancer	0.00019	0.000704	CcSEcCtD
Clarithromycin—Body temperature increased—Etoposide—testicular cancer	0.00019	0.000703	CcSEcCtD
Clarithromycin—Abdominal pain—Etoposide—testicular cancer	0.00019	0.000703	CcSEcCtD
Clarithromycin—Conjunctivitis—Doxorubicin—testicular cancer	0.00019	0.000703	CcSEcCtD
Clarithromycin—Hepatitis—Epirubicin—testicular cancer	0.00019	0.000702	CcSEcCtD
Clarithromycin—Haemorrhage—Epirubicin—testicular cancer	0.00019	0.000702	CcSEcCtD
Clarithromycin—Eye disorder—Methotrexate—testicular cancer	0.00019	0.000701	CcSEcCtD
Clarithromycin—Tinnitus—Methotrexate—testicular cancer	0.000189	0.000699	CcSEcCtD
Clarithromycin—Asthenia—Cisplatin—testicular cancer	0.000189	0.000697	CcSEcCtD
Clarithromycin—Pharyngitis—Epirubicin—testicular cancer	0.000188	0.000697	CcSEcCtD
Clarithromycin—Cardiac disorder—Methotrexate—testicular cancer	0.000188	0.000696	CcSEcCtD
Clarithromycin—Urinary tract disorder—Epirubicin—testicular cancer	0.000188	0.000693	CcSEcCtD
Clarithromycin—Haematuria—Doxorubicin—testicular cancer	0.000187	0.00069	CcSEcCtD
Clarithromycin—Connective tissue disorder—Epirubicin—testicular cancer	0.000187	0.00069	CcSEcCtD
Clarithromycin—Urethral disorder—Epirubicin—testicular cancer	0.000186	0.000688	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000185	0.000684	CcSEcCtD
Clarithromycin—Epistaxis—Doxorubicin—testicular cancer	0.000185	0.000682	CcSEcCtD
Clarithromycin—Angiopathy—Methotrexate—testicular cancer	0.000184	0.00068	CcSEcCtD
Clarithromycin—Immune system disorder—Methotrexate—testicular cancer	0.000183	0.000677	CcSEcCtD
Clarithromycin—Visual impairment—Epirubicin—testicular cancer	0.000183	0.000676	CcSEcCtD
Clarithromycin—Mediastinal disorder—Methotrexate—testicular cancer	0.000183	0.000676	CcSEcCtD
Clarithromycin—Agranulocytosis—Doxorubicin—testicular cancer	0.000183	0.000675	CcSEcCtD
Clarithromycin—Chills—Methotrexate—testicular cancer	0.000182	0.000673	CcSEcCtD
Clarithromycin—Nausea—Ifosfamide—testicular cancer	0.000181	0.000669	CcSEcCtD
Clarithromycin—Diarrhoea—Cisplatin—testicular cancer	0.00018	0.000664	CcSEcCtD
Clarithromycin—Erythema multiforme—Epirubicin—testicular cancer	0.00018	0.000664	CcSEcCtD
Clarithromycin—Mental disorder—Methotrexate—testicular cancer	0.000178	0.000657	CcSEcCtD
Clarithromycin—Eye disorder—Epirubicin—testicular cancer	0.000177	0.000656	CcSEcCtD
Clarithromycin—Hypersensitivity—Etoposide—testicular cancer	0.000177	0.000655	CcSEcCtD
Clarithromycin—Tinnitus—Epirubicin—testicular cancer	0.000177	0.000654	CcSEcCtD
Clarithromycin—Malnutrition—Methotrexate—testicular cancer	0.000177	0.000653	CcSEcCtD
Clarithromycin—Haemoglobin—Doxorubicin—testicular cancer	0.000177	0.000653	CcSEcCtD
Clarithromycin—Flushing—Epirubicin—testicular cancer	0.000176	0.000651	CcSEcCtD
Clarithromycin—Cardiac disorder—Epirubicin—testicular cancer	0.000176	0.000651	CcSEcCtD
Clarithromycin—Rhinitis—Doxorubicin—testicular cancer	0.000176	0.000651	CcSEcCtD
Clarithromycin—Hepatitis—Doxorubicin—testicular cancer	0.000176	0.000649	CcSEcCtD
Clarithromycin—Haemorrhage—Doxorubicin—testicular cancer	0.000176	0.000649	CcSEcCtD
Clarithromycin—Pharyngitis—Doxorubicin—testicular cancer	0.000174	0.000645	CcSEcCtD
Clarithromycin—Urinary tract disorder—Doxorubicin—testicular cancer	0.000174	0.000641	CcSEcCtD
Clarithromycin—Dysgeusia—Methotrexate—testicular cancer	0.000173	0.000639	CcSEcCtD
Clarithromycin—Asthenia—Etoposide—testicular cancer	0.000173	0.000638	CcSEcCtD
Clarithromycin—Connective tissue disorder—Doxorubicin—testicular cancer	0.000173	0.000638	CcSEcCtD
Clarithromycin—Angiopathy—Epirubicin—testicular cancer	0.000172	0.000637	CcSEcCtD
Clarithromycin—Urethral disorder—Doxorubicin—testicular cancer	0.000172	0.000637	CcSEcCtD
Clarithromycin—Immune system disorder—Epirubicin—testicular cancer	0.000172	0.000634	CcSEcCtD
Clarithromycin—Mediastinal disorder—Epirubicin—testicular cancer	0.000171	0.000633	CcSEcCtD
Clarithromycin—Back pain—Methotrexate—testicular cancer	0.000171	0.000632	CcSEcCtD
Clarithromycin—Chills—Epirubicin—testicular cancer	0.00017	0.00063	CcSEcCtD
Clarithromycin—Pruritus—Etoposide—testicular cancer	0.00017	0.000629	CcSEcCtD
Clarithromycin—Visual impairment—Doxorubicin—testicular cancer	0.000169	0.000626	CcSEcCtD
Clarithromycin—Vomiting—Cisplatin—testicular cancer	0.000167	0.000617	CcSEcCtD
Clarithromycin—Mental disorder—Epirubicin—testicular cancer	0.000166	0.000615	CcSEcCtD
Clarithromycin—Erythema multiforme—Doxorubicin—testicular cancer	0.000166	0.000614	CcSEcCtD
Clarithromycin—Rash—Cisplatin—testicular cancer	0.000166	0.000612	CcSEcCtD
Clarithromycin—Dermatitis—Cisplatin—testicular cancer	0.000166	0.000612	CcSEcCtD
Clarithromycin—Malnutrition—Epirubicin—testicular cancer	0.000165	0.000611	CcSEcCtD
Clarithromycin—Diarrhoea—Etoposide—testicular cancer	0.000165	0.000609	CcSEcCtD
Clarithromycin—Eye disorder—Doxorubicin—testicular cancer	0.000164	0.000607	CcSEcCtD
Clarithromycin—Ill-defined disorder—Methotrexate—testicular cancer	0.000164	0.000606	CcSEcCtD
Clarithromycin—Tinnitus—Doxorubicin—testicular cancer	0.000164	0.000606	CcSEcCtD
Clarithromycin—Anaemia—Methotrexate—testicular cancer	0.000163	0.000603	CcSEcCtD
Clarithromycin—Cardiac disorder—Doxorubicin—testicular cancer	0.000163	0.000603	CcSEcCtD
Clarithromycin—Flushing—Doxorubicin—testicular cancer	0.000163	0.000603	CcSEcCtD
Clarithromycin—Flatulence—Epirubicin—testicular cancer	0.000163	0.000602	CcSEcCtD
Clarithromycin—Tension—Epirubicin—testicular cancer	0.000162	0.0006	CcSEcCtD
Clarithromycin—Dysgeusia—Epirubicin—testicular cancer	0.000162	0.000598	CcSEcCtD
Clarithromycin—Nervousness—Epirubicin—testicular cancer	0.000161	0.000593	CcSEcCtD
Clarithromycin—Back pain—Epirubicin—testicular cancer	0.00016	0.000591	CcSEcCtD
Clarithromycin—Angiopathy—Doxorubicin—testicular cancer	0.000159	0.000589	CcSEcCtD
Clarithromycin—Malaise—Methotrexate—testicular cancer	0.000159	0.000589	CcSEcCtD
Clarithromycin—Dizziness—Etoposide—testicular cancer	0.000159	0.000588	CcSEcCtD
Clarithromycin—Muscle spasms—Epirubicin—testicular cancer	0.000159	0.000587	CcSEcCtD
Clarithromycin—Immune system disorder—Doxorubicin—testicular cancer	0.000159	0.000587	CcSEcCtD
Clarithromycin—Vertigo—Methotrexate—testicular cancer	0.000159	0.000587	CcSEcCtD
Clarithromycin—Mediastinal disorder—Doxorubicin—testicular cancer	0.000158	0.000585	CcSEcCtD
Clarithromycin—Leukopenia—Methotrexate—testicular cancer	0.000158	0.000584	CcSEcCtD
Clarithromycin—Chills—Doxorubicin—testicular cancer	0.000158	0.000583	CcSEcCtD
Clarithromycin—Nausea—Cisplatin—testicular cancer	0.000156	0.000577	CcSEcCtD
Clarithromycin—Cough—Methotrexate—testicular cancer	0.000154	0.00057	CcSEcCtD
Clarithromycin—Mental disorder—Doxorubicin—testicular cancer	0.000154	0.000569	CcSEcCtD
Clarithromycin—Ill-defined disorder—Epirubicin—testicular cancer	0.000153	0.000567	CcSEcCtD
Clarithromycin—Convulsion—Methotrexate—testicular cancer	0.000153	0.000566	CcSEcCtD
Clarithromycin—Vomiting—Etoposide—testicular cancer	0.000153	0.000566	CcSEcCtD
Clarithromycin—Malnutrition—Doxorubicin—testicular cancer	0.000153	0.000565	CcSEcCtD
Clarithromycin—Anaemia—Epirubicin—testicular cancer	0.000153	0.000565	CcSEcCtD
Clarithromycin—Agitation—Epirubicin—testicular cancer	0.000152	0.000562	CcSEcCtD
Clarithromycin—Rash—Etoposide—testicular cancer	0.000152	0.000561	CcSEcCtD
Clarithromycin—Dermatitis—Etoposide—testicular cancer	0.000152	0.00056	CcSEcCtD
Clarithromycin—Headache—Etoposide—testicular cancer	0.000151	0.000557	CcSEcCtD
Clarithromycin—Flatulence—Doxorubicin—testicular cancer	0.000151	0.000557	CcSEcCtD
Clarithromycin—Myalgia—Methotrexate—testicular cancer	0.00015	0.000556	CcSEcCtD
Clarithromycin—Chest pain—Methotrexate—testicular cancer	0.00015	0.000556	CcSEcCtD
Clarithromycin—Tension—Doxorubicin—testicular cancer	0.00015	0.000555	CcSEcCtD
Clarithromycin—Dysgeusia—Doxorubicin—testicular cancer	0.00015	0.000554	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000149	0.000552	CcSEcCtD
Clarithromycin—Malaise—Epirubicin—testicular cancer	0.000149	0.000551	CcSEcCtD
Clarithromycin—Discomfort—Methotrexate—testicular cancer	0.000149	0.000549	CcSEcCtD
Clarithromycin—Nervousness—Doxorubicin—testicular cancer	0.000149	0.000549	CcSEcCtD
Clarithromycin—Vertigo—Epirubicin—testicular cancer	0.000149	0.000549	CcSEcCtD
Clarithromycin—Leukopenia—Epirubicin—testicular cancer	0.000148	0.000547	CcSEcCtD
Clarithromycin—Back pain—Doxorubicin—testicular cancer	0.000148	0.000547	CcSEcCtD
Clarithromycin—Muscle spasms—Doxorubicin—testicular cancer	0.000147	0.000544	CcSEcCtD
Clarithromycin—Palpitations—Epirubicin—testicular cancer	0.000146	0.00054	CcSEcCtD
Clarithromycin—Confusional state—Methotrexate—testicular cancer	0.000145	0.000537	CcSEcCtD
Clarithromycin—Loss of consciousness—Epirubicin—testicular cancer	0.000145	0.000537	CcSEcCtD
Clarithromycin—Cough—Epirubicin—testicular cancer	0.000144	0.000533	CcSEcCtD
Clarithromycin—Anaphylactic shock—Methotrexate—testicular cancer	0.000144	0.000533	CcSEcCtD
Clarithromycin—Convulsion—Epirubicin—testicular cancer	0.000143	0.000529	CcSEcCtD
Clarithromycin—Infection—Methotrexate—testicular cancer	0.000143	0.000529	CcSEcCtD
Clarithromycin—Nausea—Etoposide—testicular cancer	0.000143	0.000528	CcSEcCtD
Clarithromycin—Ill-defined disorder—Doxorubicin—testicular cancer	0.000142	0.000525	CcSEcCtD
Clarithromycin—Nervous system disorder—Methotrexate—testicular cancer	0.000141	0.000523	CcSEcCtD
Clarithromycin—Anaemia—Doxorubicin—testicular cancer	0.000141	0.000523	CcSEcCtD
Clarithromycin—Thrombocytopenia—Methotrexate—testicular cancer	0.000141	0.000522	CcSEcCtD
Clarithromycin—Chest pain—Epirubicin—testicular cancer	0.000141	0.00052	CcSEcCtD
Clarithromycin—Myalgia—Epirubicin—testicular cancer	0.000141	0.00052	CcSEcCtD
Clarithromycin—Agitation—Doxorubicin—testicular cancer	0.000141	0.00052	CcSEcCtD
Clarithromycin—Anxiety—Epirubicin—testicular cancer	0.00014	0.000518	CcSEcCtD
Clarithromycin—Skin disorder—Methotrexate—testicular cancer	0.00014	0.000518	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00014	0.000517	CcSEcCtD
Clarithromycin—Hyperhidrosis—Methotrexate—testicular cancer	0.000139	0.000515	CcSEcCtD
Clarithromycin—Discomfort—Epirubicin—testicular cancer	0.000139	0.000514	CcSEcCtD
Clarithromycin—Malaise—Doxorubicin—testicular cancer	0.000138	0.00051	CcSEcCtD
Clarithromycin—Dry mouth—Epirubicin—testicular cancer	0.000138	0.000509	CcSEcCtD
Clarithromycin—Vertigo—Doxorubicin—testicular cancer	0.000137	0.000508	CcSEcCtD
Clarithromycin—Anorexia—Methotrexate—testicular cancer	0.000137	0.000508	CcSEcCtD
Clarithromycin—Leukopenia—Doxorubicin—testicular cancer	0.000137	0.000506	CcSEcCtD
Clarithromycin—Confusional state—Epirubicin—testicular cancer	0.000136	0.000503	CcSEcCtD
Clarithromycin—Palpitations—Doxorubicin—testicular cancer	0.000135	0.0005	CcSEcCtD
Clarithromycin—Anaphylactic shock—Epirubicin—testicular cancer	0.000135	0.000499	CcSEcCtD
Clarithromycin—Loss of consciousness—Doxorubicin—testicular cancer	0.000134	0.000497	CcSEcCtD
Clarithromycin—Infection—Epirubicin—testicular cancer	0.000134	0.000495	CcSEcCtD
Clarithromycin—Cough—Doxorubicin—testicular cancer	0.000133	0.000493	CcSEcCtD
Clarithromycin—Convulsion—Doxorubicin—testicular cancer	0.000133	0.00049	CcSEcCtD
Clarithromycin—Nervous system disorder—Epirubicin—testicular cancer	0.000132	0.000489	CcSEcCtD
Clarithromycin—Thrombocytopenia—Epirubicin—testicular cancer	0.000132	0.000488	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000131	0.000485	CcSEcCtD
Clarithromycin—Skin disorder—Epirubicin—testicular cancer	0.000131	0.000484	CcSEcCtD
Clarithromycin—Hyperhidrosis—Epirubicin—testicular cancer	0.00013	0.000482	CcSEcCtD
Clarithromycin—Insomnia—Methotrexate—testicular cancer	0.00013	0.000482	CcSEcCtD
Clarithromycin—Chest pain—Doxorubicin—testicular cancer	0.00013	0.000481	CcSEcCtD
Clarithromycin—Myalgia—Doxorubicin—testicular cancer	0.00013	0.000481	CcSEcCtD
Clarithromycin—Anxiety—Doxorubicin—testicular cancer	0.00013	0.00048	CcSEcCtD
Clarithromycin—Paraesthesia—Methotrexate—testicular cancer	0.000129	0.000478	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000129	0.000478	CcSEcCtD
Clarithromycin—Discomfort—Doxorubicin—testicular cancer	0.000129	0.000476	CcSEcCtD
Clarithromycin—Anorexia—Epirubicin—testicular cancer	0.000129	0.000475	CcSEcCtD
Clarithromycin—Dyspnoea—Methotrexate—testicular cancer	0.000129	0.000475	CcSEcCtD
Clarithromycin—Somnolence—Methotrexate—testicular cancer	0.000128	0.000474	CcSEcCtD
Clarithromycin—Dry mouth—Doxorubicin—testicular cancer	0.000127	0.000471	CcSEcCtD
Clarithromycin—Dyspepsia—Methotrexate—testicular cancer	0.000127	0.000469	CcSEcCtD
Clarithromycin—Confusional state—Doxorubicin—testicular cancer	0.000126	0.000465	CcSEcCtD
Clarithromycin—Decreased appetite—Methotrexate—testicular cancer	0.000125	0.000463	CcSEcCtD
Clarithromycin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000125	0.000461	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000124	0.00046	CcSEcCtD
Clarithromycin—Fatigue—Methotrexate—testicular cancer	0.000124	0.000459	CcSEcCtD
Clarithromycin—Infection—Doxorubicin—testicular cancer	0.000124	0.000458	CcSEcCtD
Clarithromycin—Pain—Methotrexate—testicular cancer	0.000123	0.000456	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000123	0.000454	CcSEcCtD
Clarithromycin—Nervous system disorder—Doxorubicin—testicular cancer	0.000122	0.000452	CcSEcCtD
Clarithromycin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000122	0.000452	CcSEcCtD
Clarithromycin—Insomnia—Epirubicin—testicular cancer	0.000122	0.000451	CcSEcCtD
Clarithromycin—Skin disorder—Doxorubicin—testicular cancer	0.000121	0.000448	CcSEcCtD
Clarithromycin—Paraesthesia—Epirubicin—testicular cancer	0.000121	0.000448	CcSEcCtD
Clarithromycin—Hyperhidrosis—Doxorubicin—testicular cancer	0.000121	0.000446	CcSEcCtD
Clarithromycin—Dyspnoea—Epirubicin—testicular cancer	0.00012	0.000445	CcSEcCtD
Clarithromycin—Somnolence—Epirubicin—testicular cancer	0.00012	0.000443	CcSEcCtD
Clarithromycin—Anorexia—Doxorubicin—testicular cancer	0.000119	0.00044	CcSEcCtD
Clarithromycin—Feeling abnormal—Methotrexate—testicular cancer	0.000119	0.000439	CcSEcCtD
Clarithromycin—Dyspepsia—Epirubicin—testicular cancer	0.000119	0.000439	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000118	0.000436	CcSEcCtD
Clarithromycin—Decreased appetite—Epirubicin—testicular cancer	0.000117	0.000433	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000116	0.000431	CcSEcCtD
Clarithromycin—Fatigue—Epirubicin—testicular cancer	0.000116	0.00043	CcSEcCtD
Clarithromycin—Pain—Epirubicin—testicular cancer	0.000115	0.000426	CcSEcCtD
Clarithromycin—Constipation—Epirubicin—testicular cancer	0.000115	0.000426	CcSEcCtD
Clarithromycin—Urticaria—Methotrexate—testicular cancer	0.000115	0.000423	CcSEcCtD
Clarithromycin—Abdominal pain—Methotrexate—testicular cancer	0.000114	0.000421	CcSEcCtD
Clarithromycin—Body temperature increased—Methotrexate—testicular cancer	0.000114	0.000421	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000114	0.00042	CcSEcCtD
Clarithromycin—Insomnia—Doxorubicin—testicular cancer	0.000113	0.000417	CcSEcCtD
Clarithromycin—Paraesthesia—Doxorubicin—testicular cancer	0.000112	0.000414	CcSEcCtD
Clarithromycin—Dyspnoea—Doxorubicin—testicular cancer	0.000111	0.000411	CcSEcCtD
Clarithromycin—Feeling abnormal—Epirubicin—testicular cancer	0.000111	0.000411	CcSEcCtD
Clarithromycin—Somnolence—Doxorubicin—testicular cancer	0.000111	0.00041	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Epirubicin—testicular cancer	0.00011	0.000408	CcSEcCtD
Clarithromycin—Dyspepsia—Doxorubicin—testicular cancer	0.00011	0.000406	CcSEcCtD
Clarithromycin—Decreased appetite—Doxorubicin—testicular cancer	0.000109	0.000401	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000108	0.000398	CcSEcCtD
Clarithromycin—Fatigue—Doxorubicin—testicular cancer	0.000108	0.000398	CcSEcCtD
Clarithromycin—Urticaria—Epirubicin—testicular cancer	0.000107	0.000396	CcSEcCtD
Clarithromycin—Pain—Doxorubicin—testicular cancer	0.000107	0.000395	CcSEcCtD
Clarithromycin—Constipation—Doxorubicin—testicular cancer	0.000107	0.000395	CcSEcCtD
Clarithromycin—Abdominal pain—Epirubicin—testicular cancer	0.000107	0.000394	CcSEcCtD
Clarithromycin—Body temperature increased—Epirubicin—testicular cancer	0.000107	0.000394	CcSEcCtD
Clarithromycin—Hypersensitivity—Methotrexate—testicular cancer	0.000106	0.000393	CcSEcCtD
Clarithromycin—Asthenia—Methotrexate—testicular cancer	0.000103	0.000382	CcSEcCtD
Clarithromycin—Feeling abnormal—Doxorubicin—testicular cancer	0.000103	0.00038	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000102	0.000377	CcSEcCtD
Clarithromycin—Pruritus—Methotrexate—testicular cancer	0.000102	0.000377	CcSEcCtD
Clarithromycin—Hypersensitivity—Epirubicin—testicular cancer	9.94e-05	0.000367	CcSEcCtD
Clarithromycin—Urticaria—Doxorubicin—testicular cancer	9.92e-05	0.000367	CcSEcCtD
Clarithromycin—Abdominal pain—Doxorubicin—testicular cancer	9.87e-05	0.000365	CcSEcCtD
Clarithromycin—Body temperature increased—Doxorubicin—testicular cancer	9.87e-05	0.000365	CcSEcCtD
Clarithromycin—Diarrhoea—Methotrexate—testicular cancer	9.86e-05	0.000365	CcSEcCtD
Clarithromycin—Asthenia—Epirubicin—testicular cancer	9.68e-05	0.000358	CcSEcCtD
Clarithromycin—Pruritus—Epirubicin—testicular cancer	9.55e-05	0.000353	CcSEcCtD
Clarithromycin—Dizziness—Methotrexate—testicular cancer	9.53e-05	0.000352	CcSEcCtD
Clarithromycin—Diarrhoea—Epirubicin—testicular cancer	9.23e-05	0.000341	CcSEcCtD
Clarithromycin—Hypersensitivity—Doxorubicin—testicular cancer	9.2e-05	0.00034	CcSEcCtD
Clarithromycin—Vomiting—Methotrexate—testicular cancer	9.17e-05	0.000339	CcSEcCtD
Clarithromycin—Rash—Methotrexate—testicular cancer	9.09e-05	0.000336	CcSEcCtD
Clarithromycin—Dermatitis—Methotrexate—testicular cancer	9.08e-05	0.000336	CcSEcCtD
Clarithromycin—Headache—Methotrexate—testicular cancer	9.03e-05	0.000334	CcSEcCtD
Clarithromycin—Asthenia—Doxorubicin—testicular cancer	8.96e-05	0.000331	CcSEcCtD
Clarithromycin—Dizziness—Epirubicin—testicular cancer	8.92e-05	0.00033	CcSEcCtD
Clarithromycin—Pruritus—Doxorubicin—testicular cancer	8.83e-05	0.000326	CcSEcCtD
Clarithromycin—Vomiting—Epirubicin—testicular cancer	8.58e-05	0.000317	CcSEcCtD
Clarithromycin—Nausea—Methotrexate—testicular cancer	8.56e-05	0.000317	CcSEcCtD
Clarithromycin—Diarrhoea—Doxorubicin—testicular cancer	8.54e-05	0.000316	CcSEcCtD
Clarithromycin—Rash—Epirubicin—testicular cancer	8.51e-05	0.000314	CcSEcCtD
Clarithromycin—Dermatitis—Epirubicin—testicular cancer	8.5e-05	0.000314	CcSEcCtD
Clarithromycin—Headache—Epirubicin—testicular cancer	8.45e-05	0.000312	CcSEcCtD
Clarithromycin—Dizziness—Doxorubicin—testicular cancer	8.26e-05	0.000305	CcSEcCtD
Clarithromycin—Nausea—Epirubicin—testicular cancer	8.01e-05	0.000296	CcSEcCtD
Clarithromycin—Vomiting—Doxorubicin—testicular cancer	7.94e-05	0.000293	CcSEcCtD
Clarithromycin—Rash—Doxorubicin—testicular cancer	7.87e-05	0.000291	CcSEcCtD
Clarithromycin—Dermatitis—Doxorubicin—testicular cancer	7.86e-05	0.000291	CcSEcCtD
Clarithromycin—Headache—Doxorubicin—testicular cancer	7.82e-05	0.000289	CcSEcCtD
Clarithromycin—Nausea—Doxorubicin—testicular cancer	7.42e-05	0.000274	CcSEcCtD
